PDCD1 and cancer: Immunotherapy is a new paradigm in cancer care, and recent advances in the field of immune checkpoint blockade have led to dramatic results, most notably with the inhibition of the programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) interaction.